By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – The stocks of many genomic tools and molecular diagnostics vendors took a hard hit for the second month in a row as the broader stock market continued its slide in August.
Registering provides access to this and other free content.
Already have an account?Login Now.
The San Diego Union Tribune wonders whether Medicare is ready for personalized medicine.
Jun Wang, the chief executive of BGI, has stepped down.
In PNAS this week: human T cell editing with CRISPR, retrotransposons acting as insulators, and more.
The New York Times' George Johnson muses on cancer's roots in multicellularity.